Soleno Therapeutics Inc. (SLNO) PT Lowered to $3 at Oppenheimer, but Sees "Considerable Upside Potential" if DCCR is "Approvable"
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell lowered the price target on Soleno Therapeutics Inc. (NASDAQ: SLNO) to $3.00 (from $5.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
